Federal judge says certain abortion drug restrictions are unlawful

A federal judge in Virginia has declared that the FDA didn't provide enough justification for the new restrictions on an abortion drug from 2023, adding to the ongoing legal battles that could significantly impact future access to abortion services. This decision underscores the contentious nature of abortion regulation, with implications for both healthcare providers and patients nationwide. As legal challenges continue, this ruling may influence the FDA's approach to drug regulations in the context of reproductive health.